Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $240.33 million. The enterprise value is $184.28 million.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 54.01 million shares outstanding. The number of shares has increased by 4.02% in one year.
| Current Share Class | 54.01M |
| Shares Outstanding | 54.01M |
| Shares Change (YoY) | +4.02% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 19.15% |
| Owned by Institutions (%) | 33.12% |
| Float | 35.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| Forward PS | 2.73 |
| PB Ratio | 3.65 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.64.
| Current Ratio | 10.22 |
| Quick Ratio | 9.22 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.67 |
Financial Efficiency
Return on equity (ROE) is -50.74% and return on invested capital (ROIC) is -18.43%.
| Return on Equity (ROE) | -50.74% |
| Return on Assets (ROA) | -16.61% |
| Return on Invested Capital (ROIC) | -18.43% |
| Return on Capital Employed (ROCE) | -32.89% |
| Weighted Average Cost of Capital (WACC) | 16.78% |
| Revenue Per Employee | $415,930 |
| Profits Per Employee | -$206,591 |
| Employee Count | 186 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, Sight Sciences has paid $10,000 in taxes.
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.83% in the last 52 weeks. The beta is 2.49, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.49 |
| 52-Week Price Change | +35.83% |
| 50-Day Moving Average | 4.25 |
| 200-Day Moving Average | 5.10 |
| Relative Strength Index (RSI) | 59.59 |
| Average Volume (20 Days) | 377,149 |
Short Selling Information
The latest short interest is 1.07 million, so 1.97% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 1.97% |
| Short % of Float | 3.02% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $77.36 million and -$38.43 million in losses. Loss per share was -$0.74.
| Revenue | 77.36M |
| Gross Profit | 66.67M |
| Operating Income | -34.30M |
| Pretax Income | -38.42M |
| Net Income | -38.43M |
| EBITDA | -33.81M |
| EBIT | -34.30M |
| Loss Per Share | -$0.74 |
Full Income StatementBalance Sheet
The company has $91.97 million in cash and $40.78 million in debt, with a net cash position of $51.19 million or $0.95 per share.
| Cash & Cash Equivalents | 91.97M |
| Total Debt | 40.78M |
| Net Cash | 51.19M |
| Net Cash Per Share | $0.95 |
| Equity (Book Value) | 63.94M |
| Book Value Per Share | 1.20 |
| Working Capital | 101.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.69 million and capital expenditures -$224,000, giving a free cash flow of -$29.92 million.
| Operating Cash Flow | -29.69M |
| Capital Expenditures | -224,000 |
| Depreciation & Amortization | 487,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -29.92M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
Gross margin is 86.17%, with operating and profit margins of -44.34% and -49.67%.
| Gross Margin | 86.17% |
| Operating Margin | -44.34% |
| Pretax Margin | -49.66% |
| Profit Margin | -49.67% |
| EBITDA Margin | -43.71% |
| EBIT Margin | -44.34% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.02% |
| Shareholder Yield | -4.02% |
| Earnings Yield | -16.32% |
| FCF Yield | -12.71% |
Analyst Forecast
The average price target for Sight Sciences is $9.08, which is 104.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.08 |
| Price Target Difference | 104.05% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.43 |
| Piotroski F-Score | 4 |
